Paragon Genomics
PrivateLast Round
Series A
Sep 12, 2017
Total Funding Raised
$8M
Company Overview
Paragon Genomics is a life science company that develops and commercializes advanced target enrichment and library preparation solutions for Next-Generation Sequencing (NGS).
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Precision Medicine
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Paragon Genomics Comparables
Compare Paragon Genomics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Pillar Biosciences | 86% | |
| SeqWell | 85% | |
| Pillar Therapeutics, Inc. | 84% | |
Paragon Genomics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Sep 12, 2017 |
Paragon Genomics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Heda Ventures | Series A |
| Cloudstone Capital | Series A |
| HEDA Ventures | Series A |
| Cowin Capital | Series A |
| Wisemont Capital | Series A |
Paragon Genomics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Paragon Genomics's valuation, stock price, and market status.